Aim-To report the collaborative experience of extracorporeal membrane oxygenation (ECMO) in the treatment of respiratory syncytial virus (RSV) bronchiolitis between April 1989 and January 1995. Methods-The medical records of patients with confirmed RSV bronchiolitis referred to three centres (Leicester, Glasgow, and Great Ormond Street) were reviewed. Results-Twenty four infants were identified. Seventeen had been born prematurely (gestational range 23-40 weeks, median 30 weeks). Thirteen infants had been mechanically ventilated after birth and seven of these had evidence of bronchopulmonary dysplasia (BPD). The age of onset of RSV infection varied from three to 64 weeks (mean 17*4 weeks, median 12 weeks). Ventilation before ECMO ranged from one to 16 days and oxygenation indices at the time of referral ranged from 21-73 (mean 39). Ribavirin was used in eight of the 24 patients. Sixteen patients received venoarterial and eight veno-venous ECMO. ECMO hours ranged from 32-647 (median 196 hours). One infant died (survival rate 96%). Cranial ultrasound abnormalities were detected in three patients. However, at follow up only one of the 23 survivors had evidence of developmental delay. Conclusion-A group of paediatric patients in whom ECMO can be of benefit has been identified. The use of ECMO should be considered when other means of support prove unsuccessfutl. (Arch Dis Child 1995; 73: F91-F94) 
Respiratory syncytial virus (RSV) causes only mild coryzal symptoms in adults and older children. However, it is a major respiratory pathogen in children under the age of 2 years' in whom it typically presents as bronchiolitis. RSV is estimated to be responsible for 40-90% of cases of bronchiolitis, overall2 3 and 80% of cases diagnosed in the first year of life,4 with a peak incidence occurring between 2 and 4 months of age.2
In most infants the illness is mild; but in about 40% of infected infants and children the lower respiratory tract will be affected. One in 100 of such patients will require treatment in hospital.5 6 In less than 3% of those cases the condition will be life-threatening6 and require intensive care and ventilation.
For previously healthy infants with bronchiolitis the prognosis is uniformly good; and although about 1% of inpatients require a period of mechanical ventilation for respiratory failure, the overall mortality reported in normal children varies from <1% to 2%.2 78In contrast to previously healthy infants, morbidity and mortality from RSV bronchiolitis are significantly higher in special risk groups with underlying cardiopulmonary disorders such as bronchopulmonary dysplasia (BPD), other types of chronic lung disease (for example, cystic fibrosis9), and congenital heart disease.
Infants with immune deficiency disease, a history of prematurity, or young infants under 6 weeks old are also more likely to develop complicated RSV infection with acute respiratory deterioration. Groothius et al reported that about 50% of children with BPD were admitted to hospital within the first two years, mainly because of viral respiratory infections, of which the respiratory syncytial virus was the commonest pathogen isolated during the winter.10 Infants receiving home oxygen during this period or shortly before were at greatest risk. Likewise, patients with congenital heart disease have an increased risk of severe disease with a reported mortality of 37%1 1 (compared with 1-5% in those without a cardiac defect); this rises to 73% in patients with pulmonary hypertension. The mortality from RSV bronchiolitis is also higher in children with primary immune deficiency (40%) and in those receiving chemotherapy (15% Accepted inclusion criteria for the use of ECMO for respiratory failure in neonates were applied -namely, potentially reversible respiratory failure, limited ventilation (< 10 days) at high airway pressure, no evidence of pre-existing neurological deficit, and no underlying bleeding disorder. The age at onset of RSV infection varied from three to 64 weeks (median 12 weeks). The mean weight on admission was 4 0 kg (range 2-0-8&4 kg; median weight 3-62 kg).
The indications for ECMO were: (1) poor oxygenation (n=22; four of whom had pneumothoraces); (2) carbon dioxide retention (n=l); (3) combination of inadequate oxygenation and carbon dioxide retention (n =1).
All patients treated with ECMO were transferred from intensive care units -most from paediatric intensive care units and adult intensive care units (ITU) at teaching hospitals. The remainder were from adult ITUs in district general hospitals. They had been mechanically ventilated for variable lengths of time (mean 6 0 days; median 5 5 increased in recent years, still remains uncommon. The final decision to refer for ECMO for our patients was based on clinical judgment. In general, the combination of deteriorating respiratory failure in spite of vigorous ventilatory support in a child with an obstructive airway disease and haemodynamic instability formed the basis of that decision. OI has proved a useful indicator for the use of ECMO in neonates as respiratory failure in newborns is usually secondary to alveolar disease and/or pulmonary hypertension. In children the pathogenesis is more heterogenous, often comprising both airway and alveolar problems, as in the patients presented here.
Infection with RSV is a major cause of admission to hospital during the winter months in temperate climates, and the mortality in those requiring intensive care is low.2 7 However, some infants with specific risk factors tend to have more severe respiratory problems when they present with RSV infection.
Eighteen of the 24 patients presented here had been premature of whom 13 had been ventilated in the neonatal period; seven had documented evidence of bronchopulmonary dysplasia (BPD). One patient had congenital heart disease (mitral regurgitation). Therefore, about 80% of patients referred for ECMO fell into special risk groups associated with more severe forms of RSV infection. Mortality among these groups when infected with RSV has been reported to be as high as 40%.8 11 Meert et al25 compared previously healthy prematurely born infants with full term infants admitted to hospital with RSV infection, and evaluated the role of prematurity on the clinical course of the illness. She found that premature birth by itself increased the risk of more severe and prolonged RSV disease. Infants who had been born prematurely developed a greater degree of respiratory insufficiency and subsequently, there was greater need for supplemental oxygen and/or mechanical ventilation. Meert further suggested that because of their smaller size and consequently smaller airway, there was a potential for increased airway resistance, hence the development of respiratory insufficiency.
Lebel et al,26 however, reported that the increased severity of RSV infection in such infants was associated with their postconceptual age rather than smaller size, because younger infants have less physiological respiratory reserve compared with matched low weight older infants. Groothuis et al,10 in a prospective study of the natural history of RSV infection in children with BPD, found that more than two thirds of these children required admission, which was generally more prolonged (exceeding seven days, whereas the hospital stay for an otherwise normal infant with RSV infection was four to seven days), and associated with significant morbidity (although there were no deaths among the study population).
Our data seem to confirm that prematurity and bronchopulmonary dysplasia do predispose group.bmj.com on June 19, 2017 -Published by http://fn.bmj.com/ Downloaded from infants to severe problems when infected with RSV. The duration of ECMO was not influenced by gestation at birth nor previous history of BPD. Moreover, pre-existing chronic lung disease did not necessarily predict a poor outcome in that six of the seven patients survived. We also found that neither a high OI nor long ventilation before ECMO were reliable predictors of the duration of ECMO and did not correlate with survival.
Most (66%) ofpatients in our study received veno-arterial (VA) support. Traditionally this has been the preferred mode of support in these haemodynamically unstable children in that it provides cardiovascular as well as respiratory support, requires a shorter operating time, and hence, stabilisation is quickly achieved. However, its disadvantages include carotid artery ligation and the risk of perfusing air bubbles or particles directly into the arterial system. Veno-venous ECMO has the advantage of sparing the carotid artery, but this technique can only be used on selected patients because of the longer operative time required to place the cannulae. Where veno-venous ECMO has been established using two separate cannulae, subsequent problems with poor healing of the groin wound and persistent leg swelling have caused concern. These complications have been resolved by the introduction of a double-lumen veno-venous catheter which provides access for drainage and perfusion. This is much less invasive but is more technically demanding to place satisfactorily.
The duration of ECMO was considerably longer in this population (mean 207 hours) compared with the neonatal population in whom ECMO hours averaged 120. Case 10 had an extremely prolonged course of venovenous extracorporeal life support (27 days) -this was a cardiac patient who had developed RSV bronchiolitis six days after mitral valve replacement, and the outcome was favourable.
It is encouraging that these infants generally had good neurological outcomes, with developmental delay documented in only one infant -an ex-premature (28 weeks' gestation) infant who had required intensive care support during the neonatal period, and was known to have dilated ventricles before referral.
ECMO entry criteria have been inadequately defined for the non-neonatal population and therefore tend to be specific to the institution. Ventilatory support before ECMO was considered optimal by referring teams, and although blood gases showed normal mean pH and pCO2, it must be emphasised that high mean airway pressures (20 (4.7) cm H20) and 100% inspired 02 were used to achieve PaO2 6-8 (1X5) kPa. Haemodynamic instability was also a significant contributing factor in referral of these patients for ECMO, many of whom were receiving inotropic support. Therefore, all patients referred to our centres for EGMO were deemed unsalvageable with maximal conventional management and 96% ultimately survived with the use of EGMO. We believe that we have identified a group of paediatric patients in whom this form of intervention can be of benefit with excellent neurological outcome and long term survival.
The United Kingdom is currently undertaking a randomised trial of ECMO compared with conventional ventilation in newborn infants. Because only small numbers of children reach ECMO criteria following RSV infection, a similar study in this population is not practical. The results presented here indicate that the use of ECMO should at least be considered when other means of support are proving unsuccessful.
